PBYI
Puma Biotechnology, Inc.
9.50$
-3.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.9% | 14.5% | 25.7% | 2.2% | 13.7% | 26.4% | 7.9% | 26.9% | 17.8% | 19.1% | 34.4% | 2.9% | 17.8% | |
| 5.1% | 4.0% | 6.6% | 6.2% | 3.6% | 4.8% | 6.1% | 5.3% | 5.0% | 3.5% | 5.8% | 4.5% | 4.5% | |
| 4.5% | 3.4% | 5.4% | 4.4% | 2.6% | 3.0% | 4.4% | 3.1% | 3.1% | 2.1% | 4.2% | 3.5% | 3.1% | |
| -2.2% | -10.4% | 24.4% | 1.6% | -17.6% | -1.4% | -9.6% | 8.0% | -6.1% | -8.7% | 32.8% | 28.7% | 9.1% | |
| 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 19.9% | -11.3% | -43.6% | 1.5% | 0.3% | -3.9% | 3.3% | -21.5% | 0.9% | -35.8% | 5.5% | 14.1% | -6.9% | |
| – | – | – | – | -13.8% | -18.8% | -24.1% | -21.2% | -20.4% | -14.7% | -24.8% | -19.7% | -19.2% | |
| 0.0% | 0.0% | 0.0% | -24.1% | -13.9% | -19.2% | -24.6% | -21.4% | -20.8% | -15.0% | -25.2% | -20.1% | -19.6% | |
| 38.8% | 3.2% | -17.9% | -20.4% | 0.1% | 3.3% | -13.5% | -16.0% | -2.1% | -31.7% | 14.6% | -3.1% | -8.7% | |
| 18.9% | 14.4% | 25.7% | 2.1% | 13.7% | 26.4% | 7.7% | 26.8% | 17.7% | 19.2% | 34.4% | 2.9% | 17.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.